Angiogenesis Analytics
1 known investors
Find your way into Angiogenesis Analytics
Sign up to see every warm intro you have to Angiogenesis Analytics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Angiogenesis Analytics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI. It is aimed at urologists, hospitals, and clinics, and is CE/MDR Class IIb certified for use in authorized EU markets.
Investors · 1
Frequently asked questions
- What does Angiogenesis Analytics do?
- PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI. It is aimed at urologists, hospitals, and clinics, and is CE/MDR Class IIb certified for use in authorized EU markets.
- Who are Angiogenesis Analytics's investors?
- Angiogenesis Analytics's investors include NLC.
